Active Community Oncology and Prevention Trials Grants

PI Name Organization - Company Titlesort descending Major Program / Research Group FOA
Ochoa, Augusto C. Lsu Health Sciences Center Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) NCI Community Oncology Research Program, NCORP Minority Underserved RFA-CA-18-017: NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
Faller, Bryan Decatur Memorial Hospital Heartland Cancer Research NCORP NCI Community Oncology Research Program, NCORP Community Sites RFA-CA-18-016: NCI Community Oncology Research Program (NCORP) Community Sites
Nelson, Christian J Sloan-Kettering Inst Can Research Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery Supportive Care and Symptom Management, Sexual Health PA-13-302: Research Project Grant
Peppone, Luke Joseph University Of Rochester High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Visovsky, Constance G. University Of South Florida Home-Based Physical Activity Intervention for Taxane-Induced CIPN Supportive Care and Symptom Management, Neuropathy PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Melemedjian, Ohannes Kevork University Of Maryland Baltimore Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy Supportive Care and Symptom Management, Neuropathy RFA-NS-18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment
Cole, Peter D Rutgers Biomedical And Health Sciences Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction PAR-16-218: Research Answers to NCIs Pediatric Provocative Questions
Plas, Ellen Van Der Arkansas Children'S Hospital Res Inst Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction PA-20-185: NIH Research Project Grant
Infante, Rodney E Ut Southwestern Medical Center Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia Supportive Care and Symptom Management, Anorexia PA-20-185: NIH Research Project Grant
Miaskowski, Christine A. University Of California, San Francisco Impact of Hearing Loss and Tinnitus in Cancer Survivors Supportive Care and Symptom Management, Other Supportive Care Issues PA-16-160: NIH Research Project Grant
Hundley, William Gregory Wake Forest University Health Sciences Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment Supportive Care and Symptom Management, Quality of Life PAR-18-307: Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
Bender, Catherine M. University Of Pittsburgh At Pittsburgh Influence of Exercise on Neurocognitive Function in Breast Cancer Supportive Care and Symptom Management, Cognitive Dysfunction PA-13-302: Research Project Grant
Fortier, Michelle University Of California-Irvine Innovative Pain and Symptom Management Program for Children with Cancer Supportive Care and Symptom Management, Pain, Pediatrics/Adolescents/Young Adult PA-16-160: NIH Research Project Grant
Abdi, Salahadin University Of Tx Md Anderson Can Ctr Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study Supportive Care and Symptom Management, Neuropathy PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Staff, Nathan P Mayo Clinic Rochester Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity Supportive Care and Symptom Management, Neuropathy PAR-21-329: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies

Pages